Phosphatidylinositol 3-kinase in myogenesis

Trends in Cardiovascular Medicine

Volumn 7, Issue 6, 1997, Pages 198-202

  Kaliman, Perla ^a   Zorzano, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

CELL DIFFERENTIATION; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0030737860     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00050-9     Document Type: Review

References (49)

1. Alema S, Tato F: 1994. Oncogenes and muscle differentiation: multiple mechanisms of interference. Cancer Biol 5:147-156.
2. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
3. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott S, Weintraub H, Verma IM: 1992. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68:507-519.
4. Brennan TJ, Edmondson DG, Li L, Olson EN: 1991. Transforming growth factor β represses the action of myogenin through a mechanism independent of DNA binding. Proc Natl Acad Sci USA 88:3822-3826.
5. Caruso M, Martelli F, Giordano A, Felsani A: 1993. Regulation of MyoD gene transcription and protein function by the transforming domains of adenovirus E1A oncoprotein. Oncogene 8:267-278.
6. Coleman ME, DeMayo F, Yin KC, et al.: 1995. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12,109-12,116.
7. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR: 1997. The mitogenic and myogenic actions of IGFs utilize distinct signaling pathways. J Biol Chem 272:6653-6662.
8. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
9. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien K, Ross J Jr: 1995. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95:619-627.
10. Edmondson DG, Olson EN: 1993. Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem 268:755-758.
11. Edwall D, Schalung M, Jennische E, Norstedt G: 1989. Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 124:820-825.
12. Ettinger SL, Lauener RW, Duronio V: 1996. Protein kinase δ specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation. J Biol Chem 271:14,514-14,518.
13. Florini JR, Ewton DZ, Magri KA: 1991a. Hormones, growth factors and myogenic differentiation. Annu Rev Physiol 53:201-216.
14. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS: 1991b. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266: 15,917-15,923.
15. Florini JR, Ewton DZ, Coolican SA: 1996. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17: 481-517.
16. Guo K, Wang J, Andres V, Smith RC, Walsh K: 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15:3823-3829.
17. Hasty P, Bradley A, Morris JH, et al.: 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501-506.
18. Hiles ID, Otsu M, Volinia S, et al.: 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70:419-429.
19. Kaliman P, Vials F, Testar X, Palacn M, Zorzano A: 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271:19,146-19,151.
20. Kong Y, Johnson SE, Taparowsky EJ, Konieczny SF: 1995. Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol Cell Biol 15:5205-5213.
21. Kou K, Rotwein PS: 1993. Transcriptional activation of the insulin-like growth factor-II gene during myoblast differentiation. Mol Endocrinol 7:291-302.
22. Lassar AB, Thayer MJ, Overell RW, Weintraub H: 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD. Cell 58:659-667.
23. Lechner C, Zahalka MA, Giot J-F, Moller NP, Ullrich A: 1996. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 93: 4355-4359.
24. Li L, Zhou J, James G, Heller-Harrison R, Czech MP, Olson EN: 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71: 1181-1194.
25. Menko AS, Boettiger D: 1987. Occupation of the extracellular matrix receptor integrin, is a control point for myogenic differentiation. Cell 51:51-57.
26. Milasincic DJ, Calera MR, Farmer SR, Pilch PF: 1996. Stimulation of C2C12 myoblast growth by bFGF and IGF-I can occur via MAP kinase-dependent and -independent pathways. Mol Cell Biol 16:5964-5973.
27. Nabeshima Y, Hanaoka K, Hayasaka M, et al.: 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535.
28. Nakanishi H, Brewer KA, Exton JH: 1993. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 268:13-16.
29. Olson EN: 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol 154:261-272.
30. Olson EN, Srivastava D: 1996. Molecular pathways controlling heart development. Science 272:671-676.
31. Otsu M, Hiles I, Gout I, et al.: 1991. Characterization of two 85 kDa proteins that associate with receptor tyrosine kinases, middle-T/ pp60c-src complexes, and PI 3-kinase. Cell 65:91-104.
32. Reiss K, Cheng W, Ferber A, et al.: 1996. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 93:8630-8635.
33. Rosen GD, Sanes JR, LaChance R, Cunningham JM, Roman J, Dean DC: 1992. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69:1107-1119.
34. Rosen KM, Wentworth BM, Rosenthal N, Villa-Komaroff L: 1993. Specific, temporally regulated expression of the insulin-like growth factor-II gene during muscle cell differentiation. Endocrinology 133:474-481.
35. Schu PV, Takegawa K, Fry MJ, Stack JH, Waterfield MD, Emr SD: 1993. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science 260:88-91.
36. Stack JH, Emr SD: 1994. Vps 34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities. J Biol Chem 269:31,552-31,562.
37. Stack JH, Dewald DB, Takegawa K, Emr SD: 1995. Vesicle-mediated protein transport: regulatory interactions between the Vps15 protein kinase and the Vps34 PtdIns 3-kinase essential for protein sorting to the vacuole in yeast. J Cell Biol 129:321-334.
38. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT: 1994. A novel phosphoinositide-3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell 77:83-93.
39. Stoyanov B, Volinia S, Hanck T, et al.: 1995. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690-693.
40. Sun XH, Copeland NG, Jenkins NA, Baltimore D: 1991. Id proteins IdI and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 11:5603-5611.
41. Thomason PA, James S, Casey PJ, Downes CP: 1994. A G-protein βγ-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol. J Biol Chem 269:16,525-16,528.
42. Toker A, Meyer M, Reddy KK, et al.: 1994. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem 269: 32,358-32,367.
43. Tollefsen S, Levis Sadow J, Rotwein P: 1989a. Coordinate expression of insulin-like growth factor-II and its receptor during muscle differentiation. Proc Natl Acad Sci USA 86:1543-1547.
44. Tollefsen S, Lajara R, McCusker RH, Clemmons DR, Rotwein P: 1989b. Insulin-like growth factors in muscle development. J Biol Chem 264:13810-13817.
45. Ui M, Okada T, Hazeki K, Hazeki O: 1995. Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem Sci 20:303-307.
46. Vanhaesebroeck B, Stein RC, Waterfield MD: 1996. The study of the phosphoinositide 3-kinase function. Cancer Surv 27:249-270.
47. Vlahos CJ, Matter WF, Hui KY, Brown RF: 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
48. Volinia S, Dhand R, Vanhaesebroeck B, et al.: 1995. A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system. EMBO J 14:3339-3348.
49. Weintraub H: 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.